Create an alert
to follow the executive moves at BeiGene.
Dermapharm has announced the acquisition of Allergopharma (posted on Feb 19, 2020).
Qualigen has announced the acquisition of Ritter Pharmaceuticals (posted on Jan 21, 2020).
Alexion Pharmaceuticals has announced the acquisition of Achillion Pharmaceuticals (posted on Dec 19, 2019).
BeiGene Announces that the Phase 3 Clinical Trial of its Anti-PD-1 Antibody Tislelizumab in Patients with First-Line Squamous Non-Small Cell Lung Cancer Met the Primary Endpoint of Progression-Free Survival at Interim Analysis | BeiGene LTD
EUSA Pharma and BeiGene Announce Exclusive Development and Commercialization Agreement for SYLVANT® and QARZIBA®▼ in Greater China | BeiGene LTD
BeiGene to Present at the 38th Annual J.P. Morgan Healthcare Conference | BeiGene LTD
Leap Therapeutics and BeiGene Announce Exclusive Option and License Agreement for DKN-01 and Leap Announces $27 Million Equity Financing | BeiGene LTD
BeiGene Announces Closing of Amgen Global Strategic Oncology Collaboration and Equity Investment | BeiGene LTD
Learn about your clients' org charts. Understand their industries and their competitors.
View the executives' biographies. Contact the executives through our email platform.
Select key words to follow your clients. Receive alerts when executive movements happen.
File your clients in folders. Add private notes. Download our data in Excel on your PC.